회원가입 | 연락처 | 사이트맵 | English       회사소개 | 리포트 | 커스텀 리서치 | 고객지원 리포트검색 정보제휴업체

로그인 카테고리 유/무선통신 전기/전자 디지털기기/미디어/방송 Information Technology 에너지 생명공학 화학/신소재 자동차 환경 일반소비재 마케팅/광고 금융 건설 교통/운송 소비자조사 방위/항공/우주 식음료 중공업 교육 기계 무역 스포츠/레저 해운/조선 패션 정부/정책 공예/귀금속 컴퍼니 프로파일 기타산업 무선통신 유선통신 차세대통신 홈네트워크 휴대폰/단말기 RFID IPTV/VoIP 통신융합 통신장비/네트워크 광통신/위성통신 국가별통신시장 기타 전자부품 디스플레이 반도체 조명/LED 로봇 센서 레이저 MEMS Embedded Software SoC 기타 디지털기기/가전 차세대정보기기 휴대용미디어기기 디지털컨텐츠 게임 방송/미디어/엔터테인먼트 STB 기타 e-Commerce e-Learning 보안 소프트웨어/서비스 인터넷 시스템장비 IT기술 기타 태양광발전 신/재생에너지 연료전지 배터리 전기/발전 석유/가스 에너지일반 기타 Digital Health/e-Health 바이오테크놀로지 생체인식 의료장비 제약 진단 헬스케어 기타 나노 신소재/신기술 플라스틱 섬유 폴리머 세라믹 금속/광물 화학 기타 전장 전자부품 텔레메틱스 전기자동차 자동차용품/산업 기타 리사이클 수처리 공기 오염 기타

현재위치 : HOME > 리포트 > Information Technology > IT기술 3D Printing for Healthcare, Trends, R&D and Revenue Forecasts 2016-2026: Explore Dental Products, Medical Implants, Pharmaceuticals, Bio-printing and Other Uses for Additive Manufacturing 발행사 Visiongain 발행일 2016-02-17 분량 245 pages 서비스형태 Report 판매가격 PDF Single User : ￡1,999 인쇄하기 Table of Contents 1. Report Overview 1.1. Overview of 3D Printing for Healthcare: Industry and Market 2015-2025 1.2. 3D Printing for Healthcare, Market Segmentation 1.3. Market Definition 1.4. How This Report Delivers 1.5. Main Questions Answered by This Analytical Report 1.6. Why You Should Read This Report 1.7. Methods of Research and Analysis 1.8. Frequently Asked Questions (FAQ) 1.9. Associated Reports 1.10. About Visiongain 2. Introduction to 3D Printing for the Healthcare Industry 2.1. 3D Printing 2.1.1. The Original 3D Printing Process 2.1.2. Selective Laser Sintering (SLS) 2.1.3. Direct Metal Laser Sintering (DMLS) 2.1.4. Electron Beam Melting (EBM) 2.1.5. Stereolithography (SLA) 2.2. Bio-printing: The Printing of Living Cells 2.2.1. How 3D Printing With Living Tissue Works 2.2.2. The Near- and Long-Term Applications for 3D Bio-printing 2.2.3. Current Problems With 3D Bio-printing 2.3. The 3D Printing of Pharmaceuticals 2.3.1. 3D Printing Technology in Drug Discovery 2.4. Classifying Medical Devices 2.4.1. The US Medical Devices Classification System 2.4.2. The EU Medical Devices Classification System 3. The 3D Printing Market for the Healthcare Industry, 2015-2025 3.1. The 3D Printing Market for Healthcare in 2013: Technology vs. Products 3.2. 3D Printed Products in the Healthcare Industry: A Breakdown by Application 3.3. The 3D Printing Market for Healthcare: A Global Revenue Forecast 2015-2025 3.4. Driving and Restraining Forces Affecting That Industry 3.5. The 3D Printing Market for Healthcare: Technology vs. Products Revenue Forecast 2015-2025 3.5.1. Technology: Revenue Forecast 2015-2025 3.5.2. Drivers and Restraints in the 3D Printing Technology Submarket 3.5.3. Products: Revenue Forecast 2015-2025 3.6. The 3D Printing Market for Healthcare: Application Submarket Revenue Forecasts 2015-2025 3.6.1. Dental Products: Revenue Forecast 2015-2025 3.6.2. Medical Implants: Revenue Forecast 2015-2025 3.6.2.1. Medical Implants: Patient-Specific Orthopaedic and Cranio-maxillofacial Implants Are Produced Using 3D Printing Technology 3.6.2.2. The Driving and Restraining Factors Surrounding 3D Printed Medical Implants, 2015 3.6.3. Bio-printed Tissue: Revenue Forecast 2015-2025 3.6.4. Bio-printed Tissue: Commercial Launch in Q4 2014 3.6.5. Other Applications: Revenue Forecast 2015-2025 3.6.6. Other Applications: Medical Modelling, Prototypes and Pharmaceuticals 4. Leading National Markets for 3D Printing in Healthcare, 2015-2025 4.1. Leading National Markets - 3D Printing for Healthcare, 2013 4.2. Leading National Markets: Comparison of Revenue and Market Share, 2019 and 2025 4.3. Leading National Markets: 3D Printing for Healthcare, Grouped Revenue Forecasts, 2015-2025 4.4. The US Will Remain the Largest National Market Throughout the Forecast Period 4.4.1. Pioneering Use of 3D Printed Medical Implants in the US 4.4.2. FDA Regulatory Requirements: Abridged Pathways Encourage Innovation 4.5. The EU5 Account for 30.55% of the Market in 2013, But How Will This Change During the Forecast Period? 4.5.1. Germany Will Remain the Largest Market of the EU5 Throughout the Forecast Period 4.5.2. France: Strong Growth but a Decreasing Market Share 4.5.3. The UK: A Strong Network for 3D Printed Medical Implants Will Stimulate Sales of those Products 4.5.4. Italian Orthopaedic Device Manufacturers are Prominent Consumers of Arcam's AM Technology 4.5.5. Spain: the Smallest Consumer in the EU5 4.6. Japan: Growth Will be Driven by Domestic and International Innovation 4.7. China: Domestic Innovation is Keeping Pace With the Western World 4.8. Will 3D Printing Penetrate the Russian Healthcare Market? 4.9. Brazil: A Rapidly Growing Dental Market Presents Opportunities for 3D Printing 4.10. The Indian Market is at an Early Stage 4.11. The RoW Market is Fast Growing 5. Market Leading Organisations in 3D Printing for Healthcare 5.1. Industry leaders in 2014 5.2. Organisations in the Medical Implants Sector 5.2.1. Stratasys: Total Revenues Up Over 80% from 2013 5.2.2. 3D Systems: 574% Growth in Healthcare Revenues since 2010 5.2.3. Tissue Regeneration Systems: Commercialising 3D Printed Bioresorbable Skeletal Reconstruction Implants 5.2.4. Oxford Performance Materials: Selling Two FDA Approved Facial Reconstruction Implants 5.2.5. EOS: A Manufacturer of 3D Printers 5.2.6. Within Technologies: A Manufacturer of Software for 3D Printing 5.2.6.1. Within Medical: A New Initiative Combining Medical Implant Design Software and a 3D Printing Manufacturing Program 5.2.7. C&A Tool: Manufacturing Parts for the Surgical, Orthopaedic, Implant and Tooling Fields 5.2.8. Tronrud Engineering: A Provider of DMLS Since November 2011 5.2.9. Alphaform AG: Focussing on its 3D Printing Business 5.2.10. 3T RPD Ltd: A UK-Based AM Company 5.2.11. Arcam AB Achieving Rapid Growth Since 2012 5.2.12. Xilloc Medical: Patient-Specific Implants from Design to Production 5.2.13. Renishaw: UK-based 3D Printer Manufacturer 5.2.14. Fripp Design and Research: Developed Picsima Technology for Printing Soft Tissue Prostheses 5.2.15. Materialise: A Global Software and Printing Services Provider 5.2.16. 4WEB Medical: Over 3000 Spinal Implants Currently In Use 5.2.17. Replica 3dm: Offering Medical Models for the NHS 5.3. Organisations in the 3D Bio-printing Sector 5.3.1. Organovo: Offering the First 3D Bio-printed Tissue for Sale 5.3.2. RegenHU: Creating 3D Bio-printers and BioInks 5.3.3. Bio 3D Technologies: The World's First Modular Bio-printer 5.3.4. Osteopore International: Two FDA Approved Products 5.3.5. EnvisionTEC: 3D Printing and Bio-printing Solutions 5.3.6. Rainbow Biosciences: Bio-printing Based on Magnetic Nanoparticles 5.3.7. Wake Forest Institute for Regenerative Medicine: 3D Bio-printing Research 5.3.7.1. Timeline for Commercially Available Therapeutic Applications 5.3.7.2. Commercial Applications: Drug Development 5.4. Organisations in Other Industry Sectors 5.4.1. Aprecia Pharmaceuticals: Oral Drug Delivery System Produced by 3D Printing Technology 5.4.2. The Cronin Group, University of Glasgow: Working on the 3D Printing of Pharmaceuticals 6. 3D Printing for the Healthcare Industry: The R&D Pipeline, 2014 6.1. R&D in the Field of Medical Implants 6.1.1. Improving Biocompatibility of 3D Printed Medical Implants with Vitamin B2 6.1.2. 3D Printed Intervertebral Discs Could Look Forward to a Share of a $90bn Market 6.1.3. 3D Printing of Bionic Organs With Enhanced Functionality 6.1.4. Returning Vision: Printing a Bionic Eye 6.2. R&D in the Field of Bioengineering 6.2.1. 3D Printing of Skin Grafts: In Hospitals Within 10 Years? 6.2.2. The Production of Implantable Cartilage Using 3D Printing 6.2.3. 3D Printing Blood Vessels is a Step Towards the Fabrication of Organs 6.2.3.1. Work at the University of Pennsylvania and MIT 6.2.3.2. Work at Fraunhofer 6.2.3.3. Work at Harvard 6.2.3.4. Work at The University of Iowa 6.2.4. 3D Printing of Replacement Ears for Reconstructive Surgery 6.2.5. 3D Printing to Fabricate Artificial Heart Valves 6.2.6. 3D Printing of Nipple Areola Complex Graft for Reconstructive Surgery 6.2.7. 3D Printing of Human Embryonic Stem Cells 6.3. R&D in Other Fields 6.3.1. The 3D Printing of Pharmaceuticals: The Potential to Improve Access to Pharmaceuticals in Remote Corners of the World? 6.3.2. 3D Printing Pills: University of Central Lancashire 6.3.3. Bio-robots for Targeted Drug Delivery 7. Qualitative Analysis of the 3D Printing Industry for Healthcare, 2015 Onwards 7.1. 3D Printing Industry for Healthcare 2014: Strengths and Weaknesses 7.1.1. Annual Growth Rate at Highest Levels To Date 7.1.2. Demand for Customised Products is High 7.1.3. 3D Printed Products Can Improve Health Outcomes and Reduce Costs 7.1.4. Time and Resources Can be Saved 7.1.5. 3D Printing Can Produce Complex Shapes and Parts 7.1.6. 3D Printing Technology is Advancing Rapidly 7.1.7. 3D Printing is Expensive 7.1.8. Economies of Scale are not Achieved Using Current Technology 7.1.9. A More Sophisticated Technology Requires Fewer Workers and New Skills 7.1.10. Access to Technology and Expertise Currently Limited 7.2. Opportunities and Threats Facing the Industry, 2015-2025 7.2.1. Governments are Funding 3D Printing R&D Projects 7.2.2. Increasing Demand for Personalised Medicine Represents a Lucrative Opportunity 7.2.3. There is Considerable Media Interest in the Technology 7.2.4. New Applications for 3D Printing Technology are Being Developed 7.2.5. Opportunities Exist in Post-Production Finishing 7.2.6. Regulatory Guidelines Must be Clarified 7.2.7. Long-term Studies of 3D Printed Medical Products Do Not Exist 7.2.8. Legal Questions Have Yet to be Answered 7.2.9. High Volume Manufacturing is More Economical Using Traditional Methods 7.3. A STEP Analysis of the 3D Printing Industry for Healthcare, 2015-2025 7.3.1. Social Influences on Market Trends 7.3.2. Technological Influences on Market Trends 7.3.3. Economic Influences on the Market 7.3.4. Political Influences on the Market 8. Research Interviews 8.1. Interview with Michael Renard, Executive Vice President, Commercial Operations, Organovo 8.1.1. On the Applications for 3D Bio-printing 8.1.2. On the Commercial Prospects of the Technology 8.1.3. On Potential Factors That Could Inhibit Development 8.1.4. On Their Newly Released exVive3D Liver Human Tissue 8.1.5. On the Future of Organovo and the 3D Bio-printing Industry 8.2. Interview with Jim Fitzsimmons, President and CEO, Tissue Regeneration Systems 8.2.1. On the Background of TRS 8.2.2. On TRS' Product Portfolio 8.2.3. On Their Commercialisation Strategy 8.2.4. On TRS' Future 8.3. Interview with Matthew Sherry, Managing Director, Replica 3dm 8.3.1. On the History Behind Replica 3dm 8.3.2. On Their Services and R&D Pipeline 8.3.3. On Replica 3dm's Growth Plans 8.3.4. On the 3D Printing For Healthcare Industry 8.4. Interview with Professor Lee Cronin, Regius Chair of Chemistry, University of Glasgow 8.4.1. On the Cronin Group's 3D Printed Technology 8.4.2. On Commercialisation Opportunities for Their Technology 8.5. Interview with Peter Leys, Executive Chairman, Materialise N.V. 8.5.1. On the Beginning of Materialise N.V. 8.5.2. On the Medical Products and Services Offered by Materialise N.V. 8.5.3. On Materialise's Most Lucrative Products and Markets in 2015 and Beyond 8.5.4. On Regulatory Challenges Facing 3D Printing in the Healthcare Industry 8.5.5. On the Prospects of Materialise N.V. Over the Forecast Period 8.6. Interview with Andy Middleton, General Manager, EMEA (Europe, Middle East and Africa), Stratasys 8.6.1. On Stratasys' Offerings for the Healthcare Industry 8.6.2. On the Demand for 3D Printing in Healthcare 8.6.3. On the Future of 3D Printing in the Healthcare Industry 8.7. Interview with Dr Lothar Koch, Head of Biofabrication Group in the Nanotechnology Department, Laser Zentrum Hannover 8.7.1. On Laser-Assisted Bio-printing 8.7.2. On the Uses of 3D Printed Tissue 8.7.3. On 3D Printed Tissue vs. Traditional In Vitro Models 8.7.4. On 3D Printed Tissue for Transplantation 8.7.5. On Research in the Field 8.7.6. On the Timeline for Commercial Availability 9. Conclusions from Our Study 9.1. The 3D Printing Market for the Healthcare Industry: Technology vs. End Products, 2015-2025 9.2. 3D Printed Products for the Healthcare Industry by Application: Comparison of Revenue, 2013, 2019 and 2025 9.3. The Leading National Markets for 3D Printing in the Healthcare Industry, 2015-2025 9.4. Trends in the Industry and Market 9.4.1. Governments Want To Be Leaders in the Field 9.4.2. Personalised Medical Products Are Penetrating The Market 9.4.3. 3D Printing Technology is Already Established in the Field of Dentistry 9.4.4. Bio-printing Will Take-Off Over The Next 10 years 9.4.5. Submarkets Will Expand - Systems, Software, Raw Materials & Products List of Tables Table 1.1: 3D Printed Products for Healthcare by Application: Revenue ($m) and Market Share (%) Forecasts, 2014-2025 Table 2.1: The US Classification of Medical Devices Table 2.2: The EU Classification of Medical Devices Table 3.1: Breakdown of the Market by Technology and Products: Revenue ($m) and Market Share (%), 2013 Table 3.2: 3D Printed Products for Healthcare by Application: Revenue ($m) and Market Share (%), 2013 Table 3.3: 3D Printing in the Healthcare Industry: Overall World Revenue ($m) Forecast, 2014-2025 Table 3.4: 3D Printing Technology for Healthcare: Revenue Forecast ($m), 2014-2025 Table 3.5: 3D Printed Products for Healthcare: Revenue Forecast ($m), 2014-2025 Table 3.6: 3D Printed Products for Healthcare by Application: Revenue ($m) and Market Share (%) Forecasts, 2014-2025 Table 3.7: 3D Printed Dental Products: Revenue ($m) and Market Share (%) Forecast, 2014-2025 Table 3.8: 3D Printed Medical Implants: Revenue ($m) and Market Share (%) Forecast, 2014-2025 Table 3.9: Bio-printed Tissue: Revenue ($m) and Market Share (%) Forecast, 2014-2025 Table 3.10: Other Applications: Revenue ($m) and Market Share (%) Forecast, 2014-2025 Table 4.1: Leading National Markets for 3D Printing Technology and 3D Printed Products for Healthcare: Revenue ($m) and Market Share (%), 2013 Table 4.2: Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Comparisons of Revenue ($m) and Market Share (%), 2019 and 2025 Table 4.3: Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Revenue Forecasts ($m), 2014-2025 Table 4.4: The US 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025 Table 4.5: The EU5: National Revenue ($m) and Market Share (%) Forecasts, 2014-2025 Table 4.6: The German 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025 Table 4.7: The French 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025 Table 4.8: The UK 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025 Table 4.9: The Italian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025 Table 4.10: The Spanish 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025 Table 4.11: The Japanese 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025 Table 4.12: The Chinese 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025 Table 4.13: The Russian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025 Table 4.14: The Brazilian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025 Table 4.15: The Indian 3D Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025 Table 4.16: RoW Printing Market for Healthcare: Revenue ($m) and Market Share (%) Forecast, 2014-2025 Table 5.1: Prominent Organisations in the 3D Printing Market for the Healthcare Industry, End of 2014 Table 5.2: Prominent Organisations in the Medical Implant Market, End of 2014 Table 5.3: Stratasys' Acquisition History, 2013-2014 Table 5.4: 3D Systems Healthcare Revenue ($m) and Share (%) of Total Revenue, 2010-2014 Table 5.5: 3D Systems Healthcare-Related Acquisition History, 2012-2014 Table 5.6: Medical Implants Designed by Within Technologies' Software, 2014 Table 5.7: Alphaform AG's Revenue ($m), 2010-2014 Table 5.8: Arcam Revenues ($m), 2010-2014 Table 5.9: Arcam: Breakdown of System Sales to the Medical Implant Industry by Country, 1997-2013 Table 5.10: Materials Used by Xilloc Medical, 2014 Table 5.11: Prominent Organisations in the 3D Bio-printing Market, 2014 Table 5.12: EnvisionTEC 3D Printing Systems for the Medical and Dental Industries, 2014 Table 5.13: Prominent Organisations in Other Industry Sectors Using 3D Printing, 2014 Table 6.1: Improving Biocompatibility of 3D Printed Medical Implants: Main Facts, 2014 Table 6.2: 3D Printing Intervertebral Discs: Main Facts, 2014 Table 6.3: 3D Printing of Bionic Organs: Main Facts, 2014 Table 6.4: 3D Printing of Bionic Eye: Main Facts, 2014 Table 6.5: 3D Printing of Skin Grafts: Main Facts, 2014 Table 6.6: 3D Printed Cartilage: Main Facts, 2014 Table 6.7: 3D Printing of Blood Vessels: Main Facts, 2014 Table 6.8: 3D Printing of Replacement Human Ears: Main Facts, 2014 Table 6.9: 3D Printing of Heart Valves: Main Facts, 2014 Table 6.10: 3D Printing of Pharmaceuticals: Main Facts, 2014 Table 7.1: Strengths and Weaknesses of the 3D Printing Industry for Healthcare, 2014-2015 Table 7.2: Opportunities and Threats Facing the Industry and Market, 2015-2025 Table 7.3: Governmental Funding for 3D Printing, 2011-2014 Table 7.4: STEP Analysis: Social, Technological, Economic and Political Forces Influencing the 3D Printing Market for Healthcare, 2015-2025 Table 7.5: Main Technological Advances in 3D Printing to End of 2014 List of Figures Figure 1.1: Global 3D Printing for Healthcare Market Segmentation Overview Figure 3.1: Breakdown of the Market by Technology and Products: Market Share (%), 2013 Figure 3.2: 3D Printed Products for Healthcare by Application: Market Share (%), 2013 Figure 3.3: 3D Printing in the Healthcare Industry: An Overarching Revenue Forecast ($m), 2015-2025 Figure 3.4: 3D Printing in the Healthcare Industry: Annual Growth Rates, 2015-2025 Figure 3.5: Driving and Restraining Factors of 3D Printing for Healthcare, 2015 Figure 3.6: 3D Printing Technology for Healthcare: Market Share (%), 2019 Figure 3.7: 3D Printing Technology for Healthcare: Revenue Forecast ($m), 2014-2025 Figure 3.8: Driving and Restraining Factors of 3D Printing Technology in the Healthcare Industry, 2015 Figure 3.9: 3D Printed Products for Healthcare: Revenue Forecast ($m), 2014-2025 Figure 3.10: 3D Printed Products and Technology for Healthcare: Market Share (%), 2025 Figure 3.11: 3D Printed Products for Healthcare by Application: Revenue Forecast ($m), 2014-2025 Figure 3.12: 3D Printed Products by Application: Market Share (%), 2025 Figure 3.13: 3D Printed Dental Products: Revenue Forecast ($m), 2014-2025 Figure 3.14: Driving and Restraining Factors of the 3D Printed Dental Product Market, 2015 Figure 3.15: 3D Printed Medical Implants: Revenue Forecast ($m), 2014-2025 Figure 3.16: Driving and Restraining Factors of the 3D Printed Medical Implants Market, 2015 Figure 3.17: Bio-printed Tissue: Revenue Forecast ($m), 2014-2025 Figure 3.18: Driving and Restraining Factors of the 3D Bio-printing Market, 2015 Figure 3.19: Other Applications: Revenue Forecast ($m), 2014-2025 Figure 3.20: The Driving and Restraining Factors of the Market for Other Applications, 2015 Figure 4.1: Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Market Share (%), 2013 Figure 4.2: Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Market Share Forecast (%), 2013, 2019, 2025 Figure 4.3: Leading National Markets for Sales of 3D Printing Technology and 3D Printed Products for Healthcare: Grouped Revenue Forecast ($m), 2014-2025 Figure 4.4: The US 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025 Figure 4.5: The EU5 3D Printing Market for Healthcare: Market Share by Country (%), 2013 Figure 4.6: The EU5: National Revenue Forecasts ($m), 2014-2025 Figure 4.7: The German 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025 Figure 4.8: The French 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025 Figure 4.9: The UK 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025 Figure 4.10: The Italian 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025 Figure 4.11: The Spanish 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025 Figure 4.12: The Japanese 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025 Figure 4.13: The Chinese 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025 Figure 4.14: The Russian 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025 Figure 4.15: The Brazilian 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025 Figure 4.16: The Indian 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025 Figure 4.17: RoW 3D Printing Market for Healthcare: Revenue Forecast ($m), 2014-2025 Figure 5.1: 3D Systems Healthcare Revenue ($m), 2010-2014 Figure 5.2: Alphaform AG's Revenue ($m), 2010-2014 Figure 5.3: Arcam: Breakdown of System Sales by Industry, 2005-2014 Figure 5.4: Arcam: Breakdown of System Sales by Location, 2005-2014 Figure 5.5: Arcam Revenues ($m), 2010-2014 Figure 5.6: Arcam: Breakdown of System Sales to the Medical Implant Industry by Country, 1997-2013 Figure 5.7: Materialise: Revenue Breakdown by Application, 2014 (Q1-Q3) Figure 6.1: 3D Printing Technology for Healthcare: Outline of the R&D Pipeline, 2014 Figure 8.1: Orthodontic Model Produced on a Stratasys Objet30 OrthoDesk 3D Printer Figure 8.2: VeinViewer® Flex Designed Using Stratasys 3D Printed Prototypes Figure 8.3: VeinViewer® Displaying Blood Beneath the Surface of an Adult Female Hand Figure 8.4: Jorge Vicente Lopes da Silva, Chief of Tridimensional Technologies Division (DT3D - CTI), Shows 12-year-old Boy's Skull Model Produced on an Objet350 Connex Multi-material 3D Printer. That child Suffered an Accident and Lost Part of his Cranium. Figure 9.1: 3D Printing for the Healthcare Industry: Revenue Forecast ($m) Broken Down Into Technology and Products, 2014-2025 Figure 9.2: 3D Printed Products for the Healthcare Industry by Application: Comparisons of Revenue ($m), 2013, 2019 and 2025 Figure 9.3: Leading National Markets in the 3D Printing Industry for Healthcare: Comparisons of Revenue ($m), 2013, 2019 and 2025 Companies Listed 3D Systems 3T RPD 4WEB Medical 5N Plus Adler Ortho Alphaform AG AP&C Aprecia Pharmaceuticals Arcam AB Asian Manufacturing Association Autodesk BestinClass SA Bio 3D Technologies Biomet Bionics Institute C&A Tool Canon Chinese Food and Drug Administration Clemson University Compass3D Cornell University CPA Group CTI Renato Archer Dante Pazzanese Cardiology Institute DePuy Synthes Deutsches Herzzentrum Berlin DiSanto Technology EnvisionTEC EOS Epson ETH Zurich European Commission European Medicines Agency FirstSurface Ltd Food and Drug Administration Formlabs Fraunhofer Institutes Fripp Design and Research Geomagic GrabCAD Hangzhou Dianzi University Harvard University Harvest Technologies Herriot-Watt University Hewlett-Packard Imaginarium Industry Alliance of China 3D Printing Technology Interfacial Solutions inVentiv Health Invetech Janssen Research and Development Johns Hopkins University Johnson & Johnson Kyoto University Graduate School of Medicine Laser Zentrum Hannover LayerWise Lima Corporate Maastricht Instruments B.V. MakerBot Manchester Metropolitan University Massachusetts Institute of Technology Materialise NV Mattel Children's Hospital MCP HEK Tooling Medical Modeling Inc. Medicines and Healthcare Regulatory Agency Medtronic Ministry of Industry and Information technology Mobelife Nakashima Medical Nano 3D Biosciences National Additive Manufacturing Innovation Institute National Institute of Health National Network for Manufacturing Innovation North Carolina State University OBL Organovo Osteopore International Oxford Performance Materials Paramount Industries Peking University 3rd Hospital Pfizer Princeton University Protosys Technologies Queen's Medical Centre QuinXell Technologies Rainbow BioSciences Rainbow Coral Corp. RedEye RegenHU Renishaw Replica 3dm Riton Biomaterial Co. Ltd Roche Roslin Cellab Royal Perth Hospital Salisbury District Hospital Simbionix Sixense SkinPrint Smith & Nephew Solid Concepts Sony DADC Stratasys Stryker Technology Strategy Board TeVido Biodevices The Cronin Group The Knight Cancer Institute of Oregon Health and Science University The Michael J Fox Foundation Tissue Regeneration Systems Tronrud TU Berlin UCLA United Therapeutics University of Central Lancashire University of Glasgow University of Iowa University of Michigan University of North Carolina University of Nottingham University of Pennsylvania University of Pittsburgh University of Sheffield University of Wisconsin US Army Vidar Systems Corp. VIVOS Dental Wake Forest Institute for Regenerative Medicine (WFIRM) Walter Reed National Military Medical Centre Weill Cornell Medical College Wellcome Trust Within Technologies World Health Organisation (WHO) Wyss Institute for Regenerative Medicine Xilloc Medical Zimmer

회사소개 | 개인정보보호정책 | 이용약관 | 배송/결제안내 | 이용안내
		서울시 강남구 논현동 210-1 삼원빌딩 | 회사명 : (주)엘앤에치 대표전화 : 02-554-0001 / 팩스 : 02-3444-5501 / 이메일 : sales@landh.co.kr Copyright ⓒ 2008 LNH, Inc. All rights reserved.